We warmly welcome you to the virtual 23rd European Multiple Myeloma Academy.
The recent years showed remarkable progress in our understanding of the biology of multiple myeloma and related diseases and led to the introduction of novel therapies increasing our options for controlling this still difficult-to-treat disease.
The EMMA meeting aims to provide a timely overview on the recent developments and most pertinent information required for state-of-the-art management of patients with multiple myeloma and amyloidosis.
The panel discussions after each major theme block open the possibility to discuss your comments and questions (by using the electronic chat box) with the speakers and will offer a deeper insight
We thank you for your attendance and involvement, and we look forward to an informative and stimulating EMMA meeting!
Heinz Ludwig and Jesús San-Miguel
Chairmen of the Meeting